MAULDIN, SC, June 10, 2021 / PRNewswire / – Xcelerate, Inc. (OTC: XCRT) announced today that it has two investment banking agreements with a leading one new York-based investment bank to help raise capital. (The investment bank was founded in the late 1980s and is one of the oldest in The United States, a full-service broker-dealer with over 300 employees. The company manages funds with over $ 2.8 billion of retail accounts, nearly 100 registered agents and 50 investment advisors in ten offices.)
Under this agreement, the company has hired the investment bank as exclusive placement agent and financial advisor in connection with acquisition finance. The company must comply with various terms and conditions that it deems appropriate and achievable.
Chairman and CEO of the company, Michael O’Shea, said, “We are extremely excited to develop this relationship with such a prestigious firm that validates our business plan. We expect that the support of this established investment banker will accelerate our growth. We have launched and embarked on an aggressive acquisition program.” Due diligence on multiple acquisition targets. Our management believes we can meet the terms of our investment banking contract. ”
ABOUT THE COMPANY
Xcelerate has assembled an internationally recognized team of translational clinicians and engineers to identify and acquire technical advances and intellectual property that have not immediately obvious medical device and clinical care applications. Xcelerate acquires engineering / patent-level innovations, marries them with appropriate early stage medical device operating companies and applies them in a controlled clinical environment that drives technical / clinical / business advancement under one roof.
SAFE HARBOR AND INFORMATION DISCLOSURE
This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including any statements that are not historical facts regarding the intentions, beliefs or current expectations of the company and its directors or its officers in relation to, among other things: (i) the Company’s financial plans; (ii) trends that have an impact on the company’s financial condition or results of operations; (iii) the company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may”, “would”, “will”, “expect”, “estimate”, “anticipate”, “believe”, “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the control of the company and that actual results could differ materially from those projected in the forward-looking statements as a result various factors, including the risk identified in the company’s registration statement and filings with the SEC. The company claims the safe haven under Section 21E (c) of the Stock Exchange Act for all forward-looking statements.
For more information on Xcelerate, Inc. please see the EDGAR filings at: http://www.sec.gov/ or by phone Justin Baronoff 561-750-9800; [email protected].
SOURCE Xcelerate, Inc.